This article is proudly sponsored by Sew Torn, a film by Diamantis Zavitsanos! Lululemon Stock’s Brutal 2025: Down 48% YTD — What Happened, and Should You Buy Now or Wait for the Real Trough? Lululemon Athletica (NASDAQ: LULU) has gone from market darling to cautionary tale in less than a year. As of August 12, 2025, […]
This article is proudly sponsored by Lake Region State College! UTIMCO’s New Buys: Reading the Tea Leaves Behind Texas’ Biggest Portfolio Moves When the University of Texas/Texas A&M Investment Management Company (UTIMCO) adjusts its portfolio, it’s worth paying attention. With roughly $65 billion under management, they’re not chasing meme stocks — they’re positioning for macro trends
UTIMCO’s New Buys: Reading the Tea Leaves Behind Texas’ Biggest Portfolio Moves Read More »
This article is proudly sponsored by Texas Student Media! Utilities Are Boring—Until They’re Not: Why Rate Cuts Make Stocks Like AEP and DUK Shockingly Interesting Let’s Be Honest: Utilities Are Not Cool Nobody brags about owning American Electric Power (AEP) at a cocktail party. Utilities don’t disrupt. They don’t pivot. They don’t scale with AI. What
This article is sponsored by College Readiness Consulting! What Did Renaissance Technologies Buy During COVID? Math, Mayo, and Monster Bets Renaissance Technologies—the most secretive, algorithmic, brainiac hedge fund on Earth—showed its hand in Q1 2020 with respect to COVID-19. And it wasn’t meme stocks. It was molecules, models, and meat (literally—hola, Chipotle). Let’s decode how
What Did Renaissance Technologies Buy During COVID? Math, Mayo, and Monster Bets Read More »
This article is sponsored by College Readiness Consulting! What Is Aflac’s Business Model? A Step-by-Step Breakdown of America’s Favorite Duck-Based Dividend Machine When you hear “Aflac!”, you probably think of that quacking duck, Nick Saban, or Deion Sanders. But behind these mascots is a multibillion-dollar insurance empire built on a surprisingly simple — and incredibly
This article is proudly sponsored by Sew Torn, a film by Diamantis Zavitsanos! What Mark Twain Can Teach You About Investing (Besides Not Putting All Your Eggs in One Steamboat) Meet Your New Investing Coach: Samuel Clemens (a.k.a. Mark Twain) He may have died in 1910, but Mark Twain could probably outmaneuver half of Wall Street
This article is proudly sponsored by Texas Student Media! Who Should Tenet Healthcare Acquire Next? Tenet Healthcare (NYSE: THC) is no stranger to consolidation. With 60+ hospitals, 110+ surgical centers, and a growing outpatient footprint, they’ve already transformed themselves from a sleepy operator into one of the leanest, most EBITDA-efficient players in U.S. healthcare. But here’s
Who Should Tenet Healthcare Acquire Next? Read More »
This article is proudly sponsored by Lake Region State College! Armstrong World Industries (AWI): Boring Ceiling Tiles? Try High-Moat Cash Machine. Armstrong World Industries makes the acoustic ceilings, grids, and architectural surfaces that keep offices quiet, schools less echo-y, hospitals compliant, and high-end lobbies looking like money. It’s not flashy—and that’s the point. The business is
Armstrong World Industries (AWI): Boring Ceiling Tiles? Try High-Moat Cash Machine. Read More »
This article is proudly sponsored by Texas Student Media! Perplexity’s $34.5 Billion Chrome Bid Is Either Brilliant Antitrust Judo—or a PR Stunt When an $18 billion AI startup tries to buy the world’s most popular browser from Google for nearly double its own valuation, you have two options: laugh—or pay very close attention. On Tuesday, Perplexity
Perplexity’s $34.5 Billion Chrome Bid Is Either Brilliant Antitrust Judo—or a PR Stunt Read More »
This article is proudly sponsored by Lake Region State College! Inside Baker Bros.’ Q1 2025 Biotech Portfolio: Massive Adds, Smart Trims, and Conviction Plays When Baker Bros. Advisors — one of biotech’s most successful hedge funds — reveals its quarterly trades, serious healthcare investors pay attention. The firm’s track record is built on deep scientific research,